Company
Cordis
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
20
510(k), De Novo and PMA
Device trials
73
As lead sponsor, any status
Adverse event reports
3,913
Received Nov 1, 2025 to Nov 20, 2026
Recall records
172
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Cordis, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Cordis.
Latest FDA decisions
The 8 newest of 20 since 2015.
- PRECISE PRO RX Transcarotid Stent SystemPMA supplement
P030047-S049 · Decided Apr 4, 2025 · 185 days after receipt · Panel Track
Device type: Stent, carotid (NIM) · Cardiology
K233637 · Decided Jun 28, 2024 · 228 days after receipt
Device type: Catheter, Percutaneous (DQY) · Cardiology
P040044-S097 · Decided Jun 27, 2024 · 210 days after receipt · Panel Track
Device type: Device, hemostasis, vascular (MGB) · Cardiology
17 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
NCT07122518 · 35 participants (planned) · Start Jun 23, 2026 · Primary completion Jun 2028
Device: PALMAZ MULLINS XD™ Pulmonary Stent · For: Pulmonary Artery Stenosis
Sites: Sacramento, California; Atlanta, Georgia; Detroit, Michigan · 8 sites in all
NCT07246902 · 339 participants · Start Nov 24, 2025 · Primary completion Aug 26, 2026
Device: MYNX CONTROLTM VENOUS Vascular Closure Device · For: Venous Vascular Closure; Electrophysiology Study
Sites: Los Angeles, California; Palo Alto, California; Littleton, Colorado · 9 sites in all
- Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure DevicePivotal-lookingCompleted
NCT03923387 · 306 participants · Start Apr 24, 2019 · Primary completion Oct 22, 2020
Device: MynxGrip · For: Endovascular
Sites: Beijing, China
70 more trials with a free account
Reports received
3,913
Received Nov 1, 2025 to Nov 20, 2026. Includes 13 of another or unstated type.
Malfunction reports
3,386
87% of reports
Injury reports
509
13% of reports
Death reports
5
0.1% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 46 | 11 | 0 | 0 |
| Jan 24 | 50 | 7 | 0 | 0 |
| Feb 24 | 46 | 5 | 0 | 0 |
| Mar 24 | 54 | 13 | 0 | 0 |
| Apr 24 | 69 | 11 | 0 | 0 |
| May 24 | 63 | 10 | 0 | 0 |
| Jun 24 | 60 | 15 | 0 | 0 |
| Jul 24 | 73 | 11 | 0 | 0 |
| Aug 24 | 49 | 13 | 1 | 0 |
| Sep 24 | 55 | 10 | 1 | 0 |
| Oct 24 | 47 | 13 | 0 | 0 |
| Nov 24 | 106 | 55 | 0 | 0 |
| Dec 24 | 206 | 64 | 0 | 0 |
| Jan 25 | 194 | 20 | 0 | 0 |
| Feb 25 | 190 | 29 | 0 | 0 |
| Mar 25 | 229 | 32 | 0 | 0 |
| Apr 25 | 238 | 15 | 0 | 0 |
| May 25 | 200 | 35 | 0 | 0 |
| Jun 25 | 211 | 31 | 0 | 0 |
| Jul 25 | 331 | 26 | 2 | 0 |
| Aug 25 | 272 | 14 | 0 | 0 |
| Sep 25 | 242 | 16 | 0 | 0 |
| Oct 25 | 277 | 20 | 0 | 0 |
| Nov 25 | 304 | 24 | 0 | 0 |
| Dec 25 | 280 | 52 | 0 | 0 |
| Jan 26 | 235 | 19 | 0 | 0 |
| Feb 26 | 212 | 46 | 0 | 0 |
| Mar 26 | 203 | 43 | 1 | 0 |
| Apr 26 | 277 | 28 | 1 | 0 |
| May 26 | 337 | 31 | 0 | 1 |
| Jun 26 | 299 | 58 | 0 | 0 |
| Jul 26 | 279 | 52 | 1 | 3 |
| Aug 26 | 292 | 64 | 0 | 6 |
| Sep 26 | 338 | 55 | 1 | 1 |
| Oct 26 | 330 | 37 | 1 | 2 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
7 more in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
- EXOSEAL1,205
- MYNX CONTROL783
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Cordis, REF C10040ML, Smart Control Vascular Stent System ILIAC, 10mm X 40mm 6F, SterileEO, Rx OnlyOpen, Classified
Z-1510-2025 · Started Mar 4, 2025 · Posted by FDA Apr 3, 2025
Reason given: product mix-up; Vascular stent labeled as one size but contains a different size.
Cause as FDA categorized it: Employee error · Device type: Stent, Iliac (NIO)
- Cordis, REF: C09060ML, Smart Control Vascular Stent System ILIAC, 9mm X 60mm 6F, SterileEO, Rx OnlyOpen, Classified
Z-1511-2025 · Started Mar 4, 2025 · Posted by FDA Apr 3, 2025
Reason given: product mix-up; Vascular stent labeled as one size but contains a different size.
Cause as FDA categorized it: Employee error · Device type: Stent, Iliac (NIO)
Z-1330-2025 · Started Feb 7, 2025 · Posted by FDA Mar 13, 2025
Reason given: Catheter manufactured at the incorrect length.
Cause as FDA categorized it: Employee error · Device type: Catheter, Percutaneous (DQY)
169 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.